aluates Reports

$ 0.0

Automative

Global Drugs for Malaria Market Research Report 2024

Published Date: January 2024

Report Code: QYRE-Auto-O228

Global Drugs for Malaria Market Insights and Forecast to 2027

BUY CHAPTERS

Global Drugs for Malaria Market Research Report 2024

Code: QYRE-Auto-O228

Report

January 2024

Pages:73

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Cipla Ltd

Guilin Pharmaceutical

Ipca Laboratories

Roche

Novartis

Sanofi Aventis

Ajanta Pharma

GlaxoSmithKline

Drugs for Malaria Market

Drugs for malaria or antimalarial medications are also known as anti-malarial drugs. Anti-malarial drugs treat or Prevention malaria, a disease that occurs in tropical, subtropical, and some temperate regions of the world. The disease is caused by a parasite, Plasmodium, which belongs to a group of one-celled organisms known as protozoa. The only way to get malaria is to be bitten by a certain type of mosquito that has bitten someone who has the disease.

Anti-malarial Drugs are available only with a physician's prescription. They come in tablet, capsule, and injectable forms. Among the commonly used anti-malarial drugs are chloroquine, mefloquine, primaquine, pyrimethamine, and quinine.

The global Drugs for Malaria market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.

In the U.S. market, the major manufacturers are Cipla, Guilin Southern Medicine, IPCA Laboratories, GlaxoSmithKline, Mylan Labs, Roche, Novartis, Sanofi Aentis and Ajanta Pharma, etc, with about 73% market shares.

This report aims to provide a comprehensive presentation of the global market for Drugs for Malaria, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Drugs for Malaria.

Report Scope

The Drugs for Malaria market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Drugs for Malaria market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Drugs for Malaria companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Drugs for Malaria Market Report

Report Metric	Details
Report Name	Drugs for Malaria Market
Segment by Type	Aryl Aminoalcohol Compounds Antifolate Compounds Artemisinin Compounds
Segment by Application	Prevention Treatment Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Cipla, Guilin Pharmaceutical, IPCA Laboratories, GlaxoSmithKline, Mylan Labs, Roche, Novartis, Sanofi Aventis, Ajanta Pharma
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Drugs for Malaria companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

What is the Cipla, IPCA Laboratories, GlaxoSmithKline, Mylan Labs, Roche, Novartis, Ajanta Pharma share in Drugs for Malaria Market?

Ans: In the U.S. market, the major manufacturers are Cipla, Guilin Southern Medicine, IPCA Laboratories, GlaxoSmithKline, Mylan Labs, Roche, Novartis, Sanofi Aentis and Ajanta Pharma, etc, with about 73% market shares.

Who are the main players in the Drugs for Malaria Market report?

Ans: The main players in the Drugs for Malaria Market are Cipla, Guilin Pharmaceutical, IPCA Laboratories, GlaxoSmithKline, Mylan Labs, Roche, Novartis, Sanofi Aventis, Ajanta Pharma

What are the Application segmentation covered in the Drugs for Malaria Market report?

Ans: The Applications covered in the Drugs for Malaria Market report are Prevention, Treatment, Others

What are the Type segmentation covered in the Drugs for Malaria Market report?

Ans: The Types covered in the Drugs for Malaria Market report are Aryl Aminoalcohol Compounds, Antifolate Compounds, Artemisinin Compounds

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Drugs for Malaria Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 Aryl Aminoalcohol Compounds

1.2.3 Antifolate Compounds

1.2.4 Artemisinin Compounds

1.3 Market by Application

1.3.1 Global Drugs for Malaria Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Prevention

1.3.3 Treatment

1.3.4 Others

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2 Global Growth Trends

2.1 Global Drugs for Malaria Market Perspective (2019-2030)

2.2 Drugs for Malaria Growth Trends by Region

2.2.1 Global Drugs for Malaria Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Drugs for Malaria Historic Market Size by Region (2019-2024)

2.2.3 Drugs for Malaria Forecasted Market Size by Region (2025-2030)

2.3 Drugs for Malaria Market Dynamics

2.3.1 Drugs for Malaria Industry Trends

2.3.2 Drugs for Malaria Market Drivers

2.3.3 Drugs for Malaria Market Challenges

2.3.4 Drugs for Malaria Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Drugs for Malaria Players by Revenue

3.1.1 Global Top Drugs for Malaria Players by Revenue (2019-2024)

3.1.2 Global Drugs for Malaria Revenue Market Share by Players (2019-2024)

3.2 Global Drugs for Malaria Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Drugs for Malaria Revenue

3.4 Global Drugs for Malaria Market Concentration Ratio

3.4.1 Global Drugs for Malaria Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Drugs for Malaria Revenue in 2023

3.5 Drugs for Malaria Key Players Head office and Area Served

3.6 Key Players Drugs for Malaria Product Solution and Service

3.7 Date of Enter into Drugs for Malaria Market

3.8 Mergers & Acquisitions, Expansion Plans

4 Drugs for Malaria Breakdown Data by Type

4.1 Global Drugs for Malaria Historic Market Size by Type (2019-2024)

4.2 Global Drugs for Malaria Forecasted Market Size by Type (2025-2030)

5 Drugs for Malaria Breakdown Data by Application

5.1 Global Drugs for Malaria Historic Market Size by Application (2019-2024)

5.2 Global Drugs for Malaria Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Drugs for Malaria Market Size (2019-2030)

6.2 North America Drugs for Malaria Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America Drugs for Malaria Market Size by Country (2019-2024)

6.4 North America Drugs for Malaria Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Drugs for Malaria Market Size (2019-2030)

7.2 Europe Drugs for Malaria Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe Drugs for Malaria Market Size by Country (2019-2024)

7.4 Europe Drugs for Malaria Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Drugs for Malaria Market Size (2019-2030)

8.2 Asia-Pacific Drugs for Malaria Market Growth Rate by Region: 2019 VS 2023 VS 2030

8.3 Asia-Pacific Drugs for Malaria Market Size by Region (2019-2024)

8.4 Asia-Pacific Drugs for Malaria Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Drugs for Malaria Market Size (2019-2030)

9.2 Latin America Drugs for Malaria Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America Drugs for Malaria Market Size by Country (2019-2024)

9.4 Latin America Drugs for Malaria Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Drugs for Malaria Market Size (2019-2030)

10.2 Middle East & Africa Drugs for Malaria Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa Drugs for Malaria Market Size by Country (2019-2024)

10.4 Middle East & Africa Drugs for Malaria Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Cipla

11.1.1 Cipla Company Detail

11.1.2 Cipla Business Overview

11.1.3 Cipla Drugs for Malaria Introduction

11.1.4 Cipla Revenue in Drugs for Malaria Business (2019-2024)

11.1.5 Cipla Recent Development

11.2 Guilin Pharmaceutical

11.2.1 Guilin Pharmaceutical Company Detail

11.2.2 Guilin Pharmaceutical Business Overview

11.2.3 Guilin Pharmaceutical Drugs for Malaria Introduction

11.2.4 Guilin Pharmaceutical Revenue in Drugs for Malaria Business (2019-2024)

11.2.5 Guilin Pharmaceutical Recent Development

11.3 IPCA Laboratories

11.3.1 IPCA Laboratories Company Detail

11.3.2 IPCA Laboratories Business Overview

11.3.3 IPCA Laboratories Drugs for Malaria Introduction

11.3.4 IPCA Laboratories Revenue in Drugs for Malaria Business (2019-2024)

11.3.5 IPCA Laboratories Recent Development

11.4 GlaxoSmithKline

11.4.1 GlaxoSmithKline Company Detail

11.4.2 GlaxoSmithKline Business Overview

11.4.3 GlaxoSmithKline Drugs for Malaria Introduction

11.4.4 GlaxoSmithKline Revenue in Drugs for Malaria Business (2019-2024)

11.4.5 GlaxoSmithKline Recent Development

11.5 Mylan Labs

11.5.1 Mylan Labs Company Detail

11.5.2 Mylan Labs Business Overview

11.5.3 Mylan Labs Drugs for Malaria Introduction

11.5.4 Mylan Labs Revenue in Drugs for Malaria Business (2019-2024)

11.5.5 Mylan Labs Recent Development

11.6 Roche

11.6.1 Roche Company Detail

11.6.2 Roche Business Overview

11.6.3 Roche Drugs for Malaria Introduction

11.6.4 Roche Revenue in Drugs for Malaria Business (2019-2024)

11.6.5 Roche Recent Development

11.7 Novartis

11.7.1 Novartis Company Detail

11.7.2 Novartis Business Overview

11.7.3 Novartis Drugs for Malaria Introduction

11.7.4 Novartis Revenue in Drugs for Malaria Business (2019-2024)

11.7.5 Novartis Recent Development

11.8 Sanofi Aventis

11.8.1 Sanofi Aventis Company Detail

11.8.2 Sanofi Aventis Business Overview

11.8.3 Sanofi Aventis Drugs for Malaria Introduction

11.8.4 Sanofi Aventis Revenue in Drugs for Malaria Business (2019-2024)

11.8.5 Sanofi Aventis Recent Development

11.9 Ajanta Pharma

11.9.1 Ajanta Pharma Company Detail

11.9.2 Ajanta Pharma Business Overview

11.9.3 Ajanta Pharma Drugs for Malaria Introduction

11.9.4 Ajanta Pharma Revenue in Drugs for Malaria Business (2019-2024)

11.9.5 Ajanta Pharma Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

Cipla Ltd

Guilin Pharmaceutical

Ipca Laboratories

Roche

Novartis

Sanofi Aventis

Ajanta Pharma

GlaxoSmithKline

List of Tables

Table 1. Global Drugs for Malaria Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of Aryl Aminoalcohol Compounds

Table 3. Key Players of Antifolate Compounds

Table 4. Key Players of Artemisinin Compounds

Table 5. Global Drugs for Malaria Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 6. Global Drugs for Malaria Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 7. Global Drugs for Malaria Market Size by Region (2019-2024) & (US$ Million)

Table 8. Global Drugs for Malaria Market Share by Region (2019-2024)

Table 9. Global Drugs for Malaria Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 10. Global Drugs for Malaria Market Share by Region (2025-2030)

Table 11. Drugs for Malaria Market Trends

Table 12. Drugs for Malaria Market Drivers

Table 13. Drugs for Malaria Market Challenges

Table 14. Drugs for Malaria Market Restraints

Table 15. Global Drugs for Malaria Revenue by Players (2019-2024) & (US$ Million)

Table 16. Global Drugs for Malaria Market Share by Players (2019-2024)

Table 17. Global Top Drugs for Malaria Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drugs for Malaria as of 2023)

Table 18. Ranking of Global Top Drugs for Malaria Companies by Revenue (US$ Million) in 2023

Table 19. Global 5 Largest Players Market Share by Drugs for Malaria Revenue (CR5 and HHI) & (2019-2024)

Table 20. Key Players Headquarters and Area Served

Table 21. Key Players Drugs for Malaria Product Solution and Service

Table 22. Date of Enter into Drugs for Malaria Market

Table 23. Mergers & Acquisitions, Expansion Plans

Table 24. Global Drugs for Malaria Market Size by Type (2019-2024) & (US$ Million)

Table 25. Global Drugs for Malaria Revenue Market Share by Type (2019-2024)

Table 26. Global Drugs for Malaria Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 27. Global Drugs for Malaria Revenue Market Share by Type (2025-2030)

Table 28. Global Drugs for Malaria Market Size by Application (2019-2024) & (US$ Million)

Table 29. Global Drugs for Malaria Revenue Market Share by Application (2019-2024)

Table 30. Global Drugs for Malaria Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 31. Global Drugs for Malaria Revenue Market Share by Application (2025-2030)

Table 32. North America Drugs for Malaria Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 33. North America Drugs for Malaria Market Size by Country (2019-2024) & (US$ Million)

Table 34. North America Drugs for Malaria Market Size by Country (2025-2030) & (US$ Million)

Table 35. Europe Drugs for Malaria Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 36. Europe Drugs for Malaria Market Size by Country (2019-2024) & (US$ Million)

Table 37. Europe Drugs for Malaria Market Size by Country (2025-2030) & (US$ Million)

Table 38. Asia-Pacific Drugs for Malaria Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030

Table 39. Asia-Pacific Drugs for Malaria Market Size by Region (2019-2024) & (US$ Million)

Table 40. Asia-Pacific Drugs for Malaria Market Size by Region (2025-2030) & (US$ Million)

Table 41. Latin America Drugs for Malaria Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 42. Latin America Drugs for Malaria Market Size by Country (2019-2024) & (US$ Million)

Table 43. Latin America Drugs for Malaria Market Size by Country (2025-2030) & (US$ Million)

Table 44. Middle East & Africa Drugs for Malaria Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 45. Middle East & Africa Drugs for Malaria Market Size by Country (2019-2024) & (US$ Million)

Table 46. Middle East & Africa Drugs for Malaria Market Size by Country (2025-2030) & (US$ Million)

Table 47. Cipla Company Detail

Table 48. Cipla Business Overview

Table 49. Cipla Drugs for Malaria Product

Table 50. Cipla Revenue in Drugs for Malaria Business (2019-2024) & (US$ Million)

Table 51. Cipla Recent Development

Table 52. Guilin Pharmaceutical Company Detail

Table 53. Guilin Pharmaceutical Business Overview

Table 54. Guilin Pharmaceutical Drugs for Malaria Product

Table 55. Guilin Pharmaceutical Revenue in Drugs for Malaria Business (2019-2024) & (US$ Million)

Table 56. Guilin Pharmaceutical Recent Development

Table 57. IPCA Laboratories Company Detail

Table 58. IPCA Laboratories Business Overview

Table 59. IPCA Laboratories Drugs for Malaria Product

Table 60. IPCA Laboratories Revenue in Drugs for Malaria Business (2019-2024) & (US$ Million)

Table 61. IPCA Laboratories Recent Development

Table 62. GlaxoSmithKline Company Detail

Table 63. GlaxoSmithKline Business Overview

Table 64. GlaxoSmithKline Drugs for Malaria Product

Table 65. GlaxoSmithKline Revenue in Drugs for Malaria Business (2019-2024) & (US$ Million)

Table 66. GlaxoSmithKline Recent Development

Table 67. Mylan Labs Company Detail

Table 68. Mylan Labs Business Overview

Table 69. Mylan Labs Drugs for Malaria Product

Table 70. Mylan Labs Revenue in Drugs for Malaria Business (2019-2024) & (US$ Million)

Table 71. Mylan Labs Recent Development

Table 72. Roche Company Detail

Table 73. Roche Business Overview

Table 74. Roche Drugs for Malaria Product

Table 75. Roche Revenue in Drugs for Malaria Business (2019-2024) & (US$ Million)

Table 76. Roche Recent Development

Table 77. Novartis Company Detail

Table 78. Novartis Business Overview

Table 79. Novartis Drugs for Malaria Product

Table 80. Novartis Revenue in Drugs for Malaria Business (2019-2024) & (US$ Million)

Table 81. Novartis Recent Development

Table 82. Sanofi Aventis Company Detail

Table 83. Sanofi Aventis Business Overview

Table 84. Sanofi Aventis Drugs for Malaria Product

Table 85. Sanofi Aventis Revenue in Drugs for Malaria Business (2019-2024) & (US$ Million)

Table 86. Sanofi Aventis Recent Development

Table 87. Ajanta Pharma Company Detail

Table 88. Ajanta Pharma Business Overview

Table 89. Ajanta Pharma Drugs for Malaria Product

Table 90. Ajanta Pharma Revenue in Drugs for Malaria Business (2019-2024) & (US$ Million)

Table 91. Ajanta Pharma Recent Development

Table 92. Research Programs/Design for This Report

Table 93. Key Data Information from Secondary Sources

Table 94. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Drugs for Malaria Market Size Comparison by Type (2024-2030) & (US$ Million)

Figure 2. Global Drugs for Malaria Market Share by Type: 2023 VS 2030

Figure 3. Aryl Aminoalcohol Compounds Features

Figure 4. Antifolate Compounds Features

Figure 5. Artemisinin Compounds Features

Figure 6. Global Drugs for Malaria Market Size Comparison by Application (2024-2030) & (US$ Million)

Figure 7. Global Drugs for Malaria Market Share by Application: 2023 VS 2030

Figure 8. Prevention Case Studies

Figure 9. Treatment Case Studies

Figure 10. Others Case Studies

Figure 11. Drugs for Malaria Report Years Considered

Figure 12. Global Drugs for Malaria Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 13. Global Drugs for Malaria Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 14. Global Drugs for Malaria Market Share by Region: 2023 VS 2030

Figure 15. Global Drugs for Malaria Market Share by Players in 2023

Figure 16. Global Top Drugs for Malaria Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drugs for Malaria as of 2023)

Figure 17. The Top 10 and 5 Players Market Share by Drugs for Malaria Revenue in 2023

Figure 18. North America Drugs for Malaria Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 19. North America Drugs for Malaria Market Share by Country (2019-2030)

Figure 20. United States Drugs for Malaria Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 21. Canada Drugs for Malaria Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 22. Europe Drugs for Malaria Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 23. Europe Drugs for Malaria Market Share by Country (2019-2030)

Figure 24. Germany Drugs for Malaria Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 25. France Drugs for Malaria Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 26. U.K. Drugs for Malaria Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 27. Italy Drugs for Malaria Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. Russia Drugs for Malaria Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. Nordic Countries Drugs for Malaria Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. Asia-Pacific Drugs for Malaria Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. Asia-Pacific Drugs for Malaria Market Share by Region (2019-2030)

Figure 32. China Drugs for Malaria Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. Japan Drugs for Malaria Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. South Korea Drugs for Malaria Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. Southeast Asia Drugs for Malaria Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. India Drugs for Malaria Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. Australia Drugs for Malaria Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 38. Latin America Drugs for Malaria Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 39. Latin America Drugs for Malaria Market Share by Country (2019-2030)

Figure 40. Mexico Drugs for Malaria Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 41. Brazil Drugs for Malaria Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 42. Middle East & Africa Drugs for Malaria Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. Middle East & Africa Drugs for Malaria Market Share by Country (2019-2030)

Figure 44. Turkey Drugs for Malaria Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. Saudi Arabia Drugs for Malaria Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. Cipla Revenue Growth Rate in Drugs for Malaria Business (2019-2024)

Figure 47. Guilin Pharmaceutical Revenue Growth Rate in Drugs for Malaria Business (2019-2024)

Figure 48. IPCA Laboratories Revenue Growth Rate in Drugs for Malaria Business (2019-2024)

Figure 49. GlaxoSmithKline Revenue Growth Rate in Drugs for Malaria Business (2019-2024)

Figure 50. Mylan Labs Revenue Growth Rate in Drugs for Malaria Business (2019-2024)

Figure 51. Roche Revenue Growth Rate in Drugs for Malaria Business (2019-2024)

Figure 52. Novartis Revenue Growth Rate in Drugs for Malaria Business (2019-2024)

Figure 53. Sanofi Aventis Revenue Growth Rate in Drugs for Malaria Business (2019-2024)

Figure 54. Ajanta Pharma Revenue Growth Rate in Drugs for Malaria Business (2019-2024)

Figure 55. Bottom-up and Top-down Approaches for This Report

Figure 56. Data Triangulation

Figure 57. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions